Novo Holdings board member steps down after less than two years in role

Carsten Stendevad has chosen to leave Novo Holdings' board as he has been given new investment responsibilities at the world's largest hedge fund, Bridgewater.
Carsten Stendevad | Photo: PR/ Bridgewater Associates
Carsten Stendevad | Photo: PR/ Bridgewater Associates
by christopher due karlsson, translated by catherine brett

After just under two years in the role of board member at Novo Nordisk fund Novo Holdings, Carsten Stendevad has chosen to step down.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading